Rankings
▼
Calendar
BEAM Q3 2023 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
BEAM
Beam Therapeutics Inc.
$3B
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$17M
+8.8% YoY
Gross Profit
-$83M
-481.9% margin
Operating Income
-$108M
-629.7% margin
Net Income
-$96M
-558.9% margin
EPS (Diluted)
$-1.22
QoQ Revenue Growth
-14.5%
Cash Flow
Operating Cash Flow
-$90M
Free Cash Flow
-$98M
Stock-Based Comp.
$26M
Balance Sheet
Total Assets
$1.3B
Total Liabilities
$512M
Stockholders' Equity
$779M
Cash & Equivalents
$169M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$17M
$16M
+8.8%
Gross Profit
-$83M
-$69M
-19.2%
Operating Income
-$108M
-$91M
-18.6%
Net Income
-$96M
-$110M
+12.3%
← FY 2023
All Quarters
Q4 2023 →